Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2365-2371
Published online before print October 28, 2004, doi: 10.1161/01.ATV.0000148707.93054.7d
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/12/2365    most recent
01.ATV.0000148707.93054.7dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, J.
Right arrow Articles by Brown, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, J.
Right arrow Articles by Brown, A. J.
Related Collections
Right arrow Remodeling
Right arrow Lipid and lipoprotein metabolism
Right arrow Pathophysiology
Right arrow Gene regulation
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2365.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Statins Inhibit Synthesis of an Oxysterol Ligand for the Liver X Receptor in Human Macrophages With Consequences for Cholesterol Flux

Jenny Wong; Carmel M. Quinn; Andrew J. Brown

From the School of Biotechnology and Biomolecular Sciences (J.W., A.J.B.), The University of New South Wales and Centre for Vascular Research at The University of New South Wales (C.M.Q.), Sydney, Australia.

Correspondence to Andrew J. Brown, PhD, School of Biotechnology and Biomolecular Sciences, Biological Sciences Building D26, University of New South Wales, Sydney, 2052, Australia. E-mail aj.brown{at}unsw.edu.au

Objective— Cholesterol efflux from macrophages in the artery wall, a key cardioprotective mechanism, is largely coordinated by the nuclear oxysterol-activated liver X receptor, LXR{alpha}. We investigated the effect of statins on LXR target gene expression and cholesterol efflux from human macrophages.

Methods and Results— In human macrophages (THP-1 cell line and primary cells), the archetypal statin, compactin, greatly reduced mRNA levels of 2 LXR target genes, ABCA1 and ABCG1 mRNA, as well as decreased cholesterol efflux. Commonly prescribed statins also downregulated LXR target gene expression in THP-1 cells. We provide several lines of evidence indicating that statins decrease expression of LXR target genes by inhibiting the synthesis of an oxysterol ligand for LXR, 24(S),25-epoxycholesterol. When THP-1 cells were cholesterol-loaded via incubation with acetylated low-density lipoprotein, synthesis of 24(S),25-epoxycholesterol was greatly reduced and the downregulatory effect of compactin on ABCA1 mRNA levels and cholesterol efflux was lost.

Conclusions— Our results suggest that statins may downregulate cholesterol efflux from nonloaded human macrophages by inhibiting synthesis of an oxysterol ligand for LXR. Further work is needed to determine how relevant our observations are to arterial foam cells in vivo.

We show that statins downregulate key genes involved in cholesterol efflux from nonloaded human macrophages. Furthermore, statin treatment drastically reduced cholesterol efflux from these cells. Moreover, we identify a likely mechanism as inhibition of the synthesis of 24(S),25-epoxycholesterol, an oxysterol ligand for the liver X receptor.


Key Words: statins • human macrophage • liver X receptor • 24(S),25-epoxycholesterol • THP-1 cells • human monocyte-derived macrophages • pleiotropic


Related Article:

24(S),25-Epoxycholesterol—A Potential Friend
Ingemar Bjorkhem and Ulf Diczfalusy
Arterioscler. Thromb. Vasc. Biol. 2004 24: 2209-2210. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Wong, C. M. Quinn, I. C. Gelissen, and A. J. Brown
Endogenous 24(S),25-Epoxycholesterol Fine-tunes Acute Control of Cellular Cholesterol Homeostasis
J. Biol. Chem., January 11, 2008; 283(2): 700 - 707.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Yan, M. I. Mayranpaa, J. Wong, J. Perttila, M. Lehto, M. Jauhiainen, P. T. Kovanen, C. Ehnholm, A. J. Brown, and V. M. Olkkonen
OSBP-related Protein 8 (ORP8) Suppresses ABCA1 Expression and Cholesterol Efflux from Macrophages
J. Biol. Chem., January 4, 2008; 283(1): 332 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Qiu and J. S. Hill
Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages
J. Lipid Res., October 1, 2007; 48(10): 2112 - 2122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Tamehiro, Y. Shigemoto-Mogami, T. Kakeya, K.-i. Okuhira, K. Suzuki, R. Sato, T. Nagao, and T. Nishimaki-Mogami
Sterol Regulatory Element-binding Protein-2- and Liver X Receptor-driven Dual Promoter Regulation of Hepatic ABC Transporter A1 Gene Expression: MECHANISM UNDERLYING THE UNIQUE RESPONSE TO CELLULAR CHOLESTEROL STATUS
J. Biol. Chem., July 20, 2007; 282(29): 21090 - 21099.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. C. Gelissen, M. Harris, K.-A. Rye, C. Quinn, A. J. Brown, M. Kockx, S. Cartland, M. Packianathan, L. Kritharides, and W. Jessup
ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Glaros, W. S. Kim, C. M. Quinn, J. Wong, I. Gelissen, W. Jessup, and B. Garner
Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway: 1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL IS A NOVEL CHOLESTEROL EFFLUX ACCELERATOR
J. Biol. Chem., July 1, 2005; 280(26): 24515 - 24523.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Argmann, J. Y. Edwards, C. G. Sawyez, C. H. O'Neil, R. A. Hegele, J. G. Pickering, and M. W. Huff
Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition: A ROLE FOR RhoA IN ABCA1-MEDIATED CHOLESTEROL EFFLUX
J. Biol. Chem., June 10, 2005; 280(23): 22212 - 22221.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Davidson
Clinical Significance of Statin Pleiotropic Effects: Hypotheses Versus Evidence
Circulation, May 10, 2005; 111(18): 2280 - 2281.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Bjorkhem and U. Diczfalusy
24(S),25-Epoxycholesterol--A Potential Friend
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2209 - 2210.
[Full Text] [PDF]